SEGMENTS

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

SEGMENTS

4. SEGMENTS

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision makers (the “CODMs”), or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision makers are the two Co-CEOs, who review and assess the performance of the Company as a whole. The Company reports its segment information to reflect the manner in which the CODMs review and assess performance. The Company has four operating segments based on the products and services we offer, which include three of our principal businesses – real estate, digital transformation technology and biohealth – as well as a fourth category consisting of certain other business activities. In determination of segments, the Company, together with its CODMs, considers factors that include the nature of business activities, allocation of resources and management structure.

The primary financial measures used by the CODMs to evaluate performance and allocate resources are net income (loss) and operating income (loss). The CODMs use net income (loss) and operating income (loss) to evaluate the performance of the Company’s ongoing operations and as part of the Company’s internal planning and forecasting processes. Information on net income (loss) and operating income (loss) is disclosed in the Consolidated Statements of Income. Segment expenses and other segment items are provided to the CODMs on the same basis as disclosed in the Consolidated Statements of Income. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

The CODMs do not evaluate performance or allocate resources based on segment assets, and therefore such information is not presented in the Notes to the Financial Statements.

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2024 and 2023:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2024
Revenue	$	19,608,184		$	-		$	-		$	1,507,715		$	21,115,899
Cost of Sales		(12,034,348	)		-			(3,370	)		(744,906	)		(12,782,624	)
Gross Margin		7,573,836			-			(3,370	)		762,809			8,333,275
Operating Expenses		(1,793,188	)		(616,403	)		(1,076,095	)		(8,964,666	)		(12,450,351	)
Operating Income (Loss)		5,780,648			(616,403	)		(1,079,465	)		(8,201,857	)		(4,117,076	)
Other Income (Expense)		1,522			(2,947,968	)		(139,737	)		3,188,229			102,046
Net Income (Loss) Before Income Tax	$	5,782,170		$	(3,564,371	)	$	(1,219,202	)	$	(5,013,628	)	$	(4,015,030	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2023
Revenue	$	20,963,661		$	28,117		$	12,758		$	1,083,971		$	22,088,507
Cost of Sales		(13,915,144	)		(9,145	)		(54,529	)		(597,391	)		(14,576,209	)
Gross Margin		7,048,517			18,972			(41,771	)		486,580			7,512,298
Operating Expenses		(1,312,024	)		(468,679	)		(869,683	)		(7,734,566	)		(10,384,952	)
Operating Income (Loss)		5,736,493			(449,707	)		(911,454	)		(7,247,986	)		(2,872,654	)
Other Income (Expense)		47,363			(6,066,133	)		(593,994	)		(51,700,965	)		(58,313,729	)
Net Income (Loss) Before Income Tax	$	5,783,856		$	(6,515,840	)	$	(1,505,448	)	$	(58,948,951	)	$	(61,186,383	)
December 31, 2024
Cash and Restricted Cash	$	4,928,236		$	326,540		$	3,375,824		$	19,553,127		$	28,183,726
Total Assets		44,683,563			3,176,729			5,446,468			43,382,430			96,761,977
December 31, 2023
Cash and Restricted Cash	$	3,323,210		$	430,807		$	568,702		$	23,566,574		$	27,889,293
Total Assets		62,989,233			5,845,269			2,450,876			55,028,650			126,314,028